News
Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.
Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a ...
Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...
Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...
She went online, got a prescription for Ozempic, and waited for her life — and body — to change. Except, Griffin seems to be one of the estimated 20 percent of people who don't find success on ...
You've probably heard of GLP-1s, a class of drugs that includes semaglutide (Ozempic). The drugs were developed to manage type 2 diabetes and are now widely being used to help with weight loss.
A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro ...
Avery, 30, revealed her shocking diagnosis of osteopenia and osteoporosis after using Ozempic for a year. She admitted to obtaining the medication without a prescription and advised others to be ...
(Carbon-neutral manufacturing, naturally.) And American consumers are hooked on Ozempic, the weight-loss drug invented, manufactured and sold by Denmark’s Novo Nordisk. The pharma firm also happens to ...
She is murderer.” At the helm of Denmark’s economic success is Novo Nordisk, the pharma company that makes Ozempic and Wegovy, blockbuster drugs for diabetes and obesity. With its all-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results